Nice Surprise News Release The news release today was a welcome surprise and took out Scotiabank wall at $1.60 and we marched up to $1.69 and back down to $1.60.
I believe all eyes will be watching to see if we announce our revised February 1st dosing. We have 2 days left in February to hit our annouced revised date.
I am starting to wonder if there are issues recruiting patients. There is no doubt in my mind they will be very selective but it is imperative we get our first patient dosed. We are already 5 months behind from initial date of Fall 2023.
I would also like an update on the number of hospitals/sites being utilized in both Turkey and Canada. Obviously the more locations the faster we will recruit suitable patients.
I can appreciate we want to screen and identify the best patients to obtain optimal results.
As previously mentioned we need data from the 3rd party peer review from phase 2 lung data to get Raymond James analyst back on our side.